Liquidity Services Inc. (LQDT) is Trading Lower on Unusual Volume for February 05

Equities Staff  |

Liquidity Services Inc. (LQDT) experienced unusually high volume on Feb. 05, as the stock lost 6.46% to a closing price of $4.71. The stock saw 506,897 shares trade hands over the course of the day on 4,293 trades. Given that the stock’s average daily volume over the last month has been 275,230 shares a day, this represents a pretty substantial spike over the norm.

Liquidity Services Inc. has a P/B ratio of 0.67. The stock has traded between $11.00 and $4.97 over the last 52-weeks, its 50-day SMA is now $6.41, and its 200-day SMA $8.21.

Liquidity Service Inc is an online auction marketplace for surplus and salvage assets. It enables buyers and sellers to transact in an efficient, automated online auction environment offering over approximately 500 product categories.

Headquartered in Washington, DC, Liquidity Services Inc. has 1,179 employees and is currently under the leadership of CEO William P. Angrick.

For a complete fundamental analysis analysis of Liquidity Services Inc., check out’s Stock Valuation Analysis report for LQDT. To see the latest independent stock recommendations from’s analysts, visit our Research section.


The Russell 3000 is not well known outside the world of finance, but it’s one of the strongest indices out there for getting a broad sense of the stock market. Unlike the better-known Dow Jones Industrial Average or S&P 500, membership on the Russell 3000 isn’t selected by committee. It’s simply the 3,000 most valuable companies in the country.

With 3,000 stocks making up the index, it gives a broad look at the markets, including the small-and mid-cap companies that aren’t on the Dow or the S&P 500. And with a rules-based system for determining membership, there’s no bias that could potentially limit membership. That’s why many financial professionals will turn to the Russell 3000 long before the better-known indices when trying to take the temperature of the market.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


What Is Petrolithium?

MGX Minerals explains the advantages of petrolithium and how they are helping to solve future problems today.

Emerging Growth

IMV Inc.

Immunovaccine Inc is clinical stage biopharmaceutical company. The Company develops products based on its proprietary vaccine enhancement platform in T cell activating therapies for cancer.